📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Re: Heng Li, Yucong Zhang, Dong Li, et al. Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy. Eur Urol 2021;79:879-86 AR-V7 is Rare in Hormone-sensitive Prostate Cancer (2022)

First Author: Sowalsky A

Attributed to: BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.eururo.2022.06.028

PubMed Identifier: 36038450

Publication URI: http://europepmc.org/abstract/MED/36038450

Type: Journal Article/Review

Parent Publication: European Urology

Issue: 5

ISSN: 0302-2838